- Report
- May 2024
- 200 Pages
Global
From €3966EUR$4,150USD£3,374GBP
- Conference
- June 2024
- 2 Days
Global
€1580EUR$1,711USD£1,299GBP
- Conference
- October 2024
- 2 Days
Global
€1337EUR$1,448USD£1,099GBP
€1580EUR$1,711USD£1,299GBP
- Conference
- October 2024
- 2 Days
Global
€1337EUR$1,448USD£1,099GBP
€1580EUR$1,711USD£1,299GBP
- Conference
- July 2024
- 2 Days
Global
€1337EUR$1,448USD£1,099GBP
€1580EUR$1,711USD£1,299GBP
- Report
- April 2023
- 214 Pages
Global
From €3440EUR$3,600USD£2,927GBP
- Report
- April 2023
- 65 Pages
North America
From €1433EUR$1,500USD£1,220GBP
- Report
- April 2023
- 77 Pages
Middle East, Africa
From €1433EUR$1,500USD£1,220GBP
- Report
- April 2023
- 77 Pages
Europe
From €1433EUR$1,500USD£1,220GBP
- Report
- April 2023
- 77 Pages
Asia Pacific
From €1433EUR$1,500USD£1,220GBP
Veterinary Pharmacovigilance is a field of animal healthcare that focuses on the safety of veterinary medicines. It involves the collection, analysis, and reporting of adverse events associated with the use of veterinary medicines. Veterinary Pharmacovigilance also includes the monitoring of the effectiveness of veterinary medicines, as well as the identification of potential risks associated with their use. The goal of Veterinary Pharmacovigilance is to ensure that veterinary medicines are safe and effective for use in animals.
Veterinary Pharmacovigilance is an important part of animal healthcare, as it helps to ensure that veterinary medicines are used safely and effectively. It also helps to identify potential risks associated with the use of veterinary medicines, and to ensure that these risks are minimized.
Some companies in the Veterinary Pharmacovigilance market include Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Zoetis, and Virbac. Show Less Read more